Cover Image
Market Research Report - 228358

Injectable Drug Delivery Devices, Markets and Forecasts

Published by Greystone Research Associates
Published Content info
Price
Back to Top
Injectable Drug Delivery Devices, Markets and Forecasts
Published: January 1, 2016 Content info:
Description

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

What You Will Learn

  • What injectable drugs are currently marketed, how are they administered, what are the device specifics, and who markets them?
  • What are the injection device types that are driving the market? What is their market share and who are the leading suppliers?
  • What new injection device classes have recently been launched and was is their probable impact going to be on the injectables sector?
  • What does the injectable drugs supply chain consist of, who are the key suppliers, their manufacturing infrastructure and locations, their capabilities?
  • What are the major factors driving injectable drug demand?
  • How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
  • What is the size & breakdown of the injectable drug market today? What will it look like in 2022?
Table of Contents

Table of Contents

Injectable Drug Delivery - Summary of Contents

Executive Summary

Injectable Drug Market Dynamics

  • The Injectable Drug Ecosystem
  • Injectable Drug Demand Drivers
  • Drug Development Factors
  • Market Factors
  • Technology Factors
  • Competitive Landscape
  • Risks and Opportunities

Injectable Drug-Device Selection Criteria

  • Stability and Material Selection Issues
  • Single vs Multi-Dose Devices
  • Lyophilized Drugs/Reconstitution
  • Syringe Safety/Sharps Protection
  • Needle Configuration Strategies
  • Disposable Drug Cartridges
  • Human Engineering/Ergonomics
  • Branding/Private Labeling

Injectable Drug Delivery - Device Segments

  • Autoinjectors
  • Autoinjector-specific Selection Factors
  • Autoinjector Device Categories
  • Drugs and Therapeutic Segments
  • Needle-free Injectors
  • Device Categories
  • Needle-free Injector-specific Selection Factors
  • Pen Injectors
  • Pen Injector Device Categories
  • Branded Drug/Pen Injector Product by Segment
  • Prefilled Syringes
  • Prefilled Syringe Device Categories
  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes
  • Safety Syringes
  • Prefillable Integrated Safety Syringes
  • Non-Prefillable Integrated Safety Syringes
  • Wearable Injectors
  • Patch Injectors
  • Subcutaneous Infusion Devices

Injectable Drug Delivery - Therapeutic Segment Analysis & Forecasts

  • Anaphylaxis
  • Anticoagulants
  • Antivirals
  • Autoimmune Diseases
  • Emergency Medicine
  • Hematopoietics
  • Hormone Replacement
  • Metabolic Diseases
  • Neurology
  • Reproductive Health
  • Vaccines

Injectable Drug Therapeutics - Market Factors

  • Regulatory Factors and Issues
  • Sharps Legislation
  • Managed Care & Healthcare Economics

Company Profiles

Back to Top